Since A46 has been characterized as an antagonist of host IL-1 and TLR-signaling [26], quantifying the IL-1β secreted after activation of these pathways, by MVA infection, might be a way to measure the biological effect of presence/absence of A46. Here, IL1B is linked to infection.